Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome

被引:13
作者
Tang, Binbin [1 ,2 ]
Hu, Yunlian [3 ,4 ]
Chen, Jianhui [3 ,4 ]
Su, Chengxia [3 ,4 ]
Zhang, Qian [3 ,4 ]
Huang, Chaoqun [3 ,4 ]
机构
[1] Tongde Hosp Zhejiang Prov, Outpatient Dept 2, Hangzhou, Peoples R China
[2] Hubei Univ Chinese Med, Clin Coll Tradit Chinese Med, Wuhan, Peoples R China
[3] Hubei Prov Hosp Tradit Chinese Med, Dept Gastroenterol, Wuhan, Peoples R China
[4] Hubei Univ Chinese Med, Clin Coll 1, Wuhan, Peoples R China
关键词
Fecal microbiota; Oral microbiota; Irritable bowel syndrome; Diarrhea; INFLAMMATION;
D O I
10.1016/j.heliyon.2023.e13114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: This study aimed at investigating the characteristics and correlation between oral (tongue coating) and fecal microbiota in patients with diarrheal irritable bowel syndrome (IBS-D).Methods: Fifty-two IBS-D patients were chosen, with ten healthy volunteers serving as the normal control group. Tongue coating samples and fecal samples of subjects were sequenced for the 16S rRNA gene (V4-V5). Bioinformatics analysis was done on the test data to investigate oral and fecal microbiota composition characteristics in IBS-D patients.Results: The microbial richness of tongue coating in IBS-D group was lower than that in the normal control group (P < 0.05). The beta diversity of tongue coating microbiota and fecal microbiota was significantly different in the IBS-D group compared to the normal control group (P < 0.05). Pseudomonadales (Pseudomonadaceae and Pseudomonas), Moraxellaceae, Parvimonas, Peptos-treptococcus, and Alloprevotella were considerably high in number the tongue coating samples of the IBS-D group in comparison to the normal control group. Similarly, the fecal samples from the IBS-D group were significantly enriched in Alphaproteobacteria, Pseudomonadales (Pseudomona-daceae and Pseudomonas), Acidaminococcaceae, Phascolarctobacterium, Alloprevotella, and Escher-ichia compared to the normal control group.Conclusions: The oral and fecal microbiotas of IBS-D patients differ from those of the control group; hence studying IBS-D from the perspective of the oral-gut microbiome axis is an interesting research avenue.
引用
收藏
页数:10
相关论文
共 50 条
[41]   Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study [J].
Altomare, Annamaria ;
Del Chierico, Federica ;
Rocchi, Giulia ;
Emerenziani, Sara ;
Nuglio, Chiara ;
Putignani, Lorenza ;
Angeletti, Silvia ;
Lo Presti, Alessandra ;
Ciccozzi, Massimo ;
Russo, Alessandra ;
Cocca, Silvia ;
Ribolsi, Mentore ;
Muscaritoli, Maurizio ;
Cicala, Michele ;
Guarino, Michele Pier Luca .
NUTRIENTS, 2021, 13 (05)
[42]   Does fecal calprotectin increase may be linked to lactose intolerance in patients with irritable bowel syndrome? [J].
De Rivery, Marine Guingand ;
Zeinab, Hamidou ;
Cohen, Valerie ;
Baumstarck, Karine ;
Luciano, Laure ;
Vitton, Veronique .
MINERVA GASTROENTEROLOGY, 2023, 69 (03) :329-334
[43]   Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome [J].
Mizuno, Shinta ;
Masaoka, Tatsuhiro ;
Naganuma, Makoto ;
Kishimoto, Taishiro ;
Kitazawa, Momoko ;
Kurokawa, Shunya ;
Nakashima, Moeko ;
Takeshita, Kozue ;
Suda, Wataru ;
Mimura, Masaru ;
Hattori, Masahira ;
Kanai, Takanori .
DIGESTION, 2017, 96 (01) :29-38
[44]   Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients [J].
Sun, Qing Hua ;
Liu, Zuo Jing ;
Zhang, Lu ;
Wei, Hui ;
Song, Li Jin ;
Zhu, Shi Wei ;
He, Mei Bo ;
Duan, Li Ping .
JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (05) :246-255
[45]   Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials [J].
Wu, Jie ;
Lv, Liang ;
Wang, Chunlian .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
[46]   Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota [J].
Huang, Hong Li ;
Chen, Hui Ting ;
Luo, Qing Ling ;
Xu, Hao Ming ;
He, Jie ;
Li, Yong Qiang ;
Zhou, You Lian ;
Yao, Fei ;
Nie, Yu Qiang ;
Zhou, Yong Jian .
JOURNAL OF DIGESTIVE DISEASES, 2019, 20 (08) :401-408
[47]   Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy [J].
Konturek P.C. ;
Zopf Y. .
MMW - Fortschritte der Medizin, 2017, 159 (Suppl 7) :1-5
[48]   Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects [J].
Chung, Chen-Shuan ;
Chang, Pi-Feng ;
Liao, Chun-Hsing ;
Lee, Tzong-Hsi ;
Chen, Yun ;
Lee, Yi-Chia ;
Wu, Ming-Shiang ;
Wang, Hsiu-Po ;
Ni, Yen-Hsuan .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (04) :410-419
[49]   Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis [J].
Myneedu, Kanchana ;
Deoker, Abhizith ;
Schmulson, Max J. ;
Bashashati, Mohammad .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (08) :1033-1041
[50]   Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome [J].
Almansa, Cristina ;
Agrawal, Anurag ;
Houghton, Lesley A. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (03) :383-398